A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Phase of Trial: Phase IV
Latest Information Update: 28 May 2018
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Biomarker; Pharmacodynamics
- Acronyms VIP
- 23 Apr 2018 Status changed from active, no longer recruiting to completed.
- 11 Jun 2015 Status changed from not yet recruiting to active,no longer recruiting as reported by ClinicalTrials.gov.
- 27 Jul 2012 Actual initiation date (July 2012) added as reported by ClinicalTrials.gov.